S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

TLPH Talphera Inc

0.69

0.0603 (9.58%)

After Hours

Last Updated: 08:51:40

Delayed by 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

12/02/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Jordyn Davis as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for ASADORIAN RAFFI

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Talphera (NASDAQ:TLPH)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Talphera Charts.

Talphera (NASDAQ:TLPH)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Talphera Charts.

Talphera Inc News

Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study
Wednesday 15 January 2025 (3 weeks ago) • PR Newswire (US)

Form 8-K - Current report
Thursday 12 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 6 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 3 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 3 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 3 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 30 November 2024 (2 months ago) • Edgar (US Regulatory)

Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors
Monday 25 November 2024 (2 months ago) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (3 months ago) • Edgar (US Regulatory)

Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update
Thursday 14 November 2024 (3 months ago) • PR Newswire (US)

Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024
Thursday 7 November 2024 (3 months ago) • PR Newswire (US)

Form 3 - Initial statement of beneficial ownership of securities
Friday 11 October 2024 (4 months ago) • Edgar (US Regulatory)

More Talphera Inc News Articles

BNP Paribas Issuance

Pioneer Natural Resources

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions